NCT05225298View on ClinicalTrials.gov

SARS-COV-2 Screening in Dialysis Facilities

NACompletedINTERVENTIONAL
Enrollment

2,389

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

August 1, 2023

Study Completion Date

October 1, 2023

Conditions
End-stage Renal DiseaseSARS-CoV-2 Acute Respiratory DiseaseDialysis; Complications
Interventions
BEHAVIORAL

Offering SARS-CoV-2 test

A pragmatic cluster (facility-level) randomized clinical trial, comparing test-based screening performed at a static (every two weeks) frequency versus a dynamic frequency (ranging from once a week to once every four weeks) anchored to county COVID-19 case rates

Trial Locations (1)

75024

US Renal Care, Plano

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER